{"id":"carbetocin","rwe":[{"pmid":"41866582","year":"2026","title":"Telemedical management of severe postpartum hemorrhagic vaginal discharge in a sow - a case report.","finding":"","journal":"Porcine health management","studyType":"Clinical Study"},{"pmid":"41844474","year":"2026","title":"Uterotonics in pregnant patients with cardiac disease: a focused review.","finding":"","journal":"International journal of obstetric anesthesia","studyType":"Clinical Study"},{"pmid":"41736500","year":"2026","title":"Prophylactic carbetocin versus oxytocin following vaginal delivery among women with high risk for postpartum hemorrhage: A before-and-after study.","finding":"","journal":"Acta obstetricia et gynecologica Scandinavica","studyType":"Clinical Study"},{"pmid":"41730820","year":"2026","title":"Carbetocin - a long-acting oxytocin analogue - increases the blood supply to the reproductive tract of rams.","finding":"","journal":"Domestic animal endocrinology","studyType":"Clinical Study"},{"pmid":"41722142","year":"2026","title":"Effect of dimethyl sulfoxide (DMSO) associated with oxytocin (carbetocin) on collagenase activity (in vitro) and cervical penetrability (in vivo) in sheep.","finding":"","journal":"Theriogenology","studyType":"Clinical Study"}],"tags":[{"label":"carbetocin","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Oxytocin receptor","category":"target"},{"label":"OXTR","category":"gene"},{"label":"AVPR1A","category":"gene"},{"label":"AVPR2","category":"gene"},{"label":"H01BB03","category":"atc"},{"label":"Active","category":"status"},{"label":"Atony of uterus","category":"indication"},{"label":"Prader-Willi syndrome","category":"indication"},{"label":"Ferring Pharmaceuticals Ltd","category":"company"},{"label":"Delayed-Action Preparations","category":"pharmacology"},{"label":"Oxytocics","category":"pharmacology"},{"label":"Reproductive Control Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Ferring Pharmaceuticals Ltd","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CARBETOCIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:21:52.053492+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:21:58.542172+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CARBETOCIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:21:58.758653+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Oxytocin receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:22:00.079521+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3301668/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:21:59.460903+00:00"}},"allNames":"pabal","offLabel":[],"synonyms":["pabal","carbetocin","depotocin","duratocin"],"timeline":[{"date":"2007-11-05","type":"positive","source":"DrugCentral","milestone":"UK Medicines and Healthcare Products Regulatory Agency (MHRA) approval (Ferring Pharmaceuticals Ltd)"}],"brandName":"Pabal","ecosystem":[{"indication":"Atony of uterus","otherDrugs":[],"globalPrevalence":null},{"indication":"Prader-Willi syndrome","otherDrugs":[{"name":"somatropin","slug":"somatropin","company":"Serono"}],"globalPrevalence":null}],"mechanism":{"target":"Oxytocin receptor","targets":[{"gene":"OXTR","source":"DrugCentral","target":"Oxytocin receptor","protein":"Oxytocin receptor"},{"gene":"AVPR1A","source":"DrugCentral","target":"Vasopressin V1a receptor","protein":"Vasopressin V1a receptor"},{"gene":"AVPR2","source":"DrugCentral","target":"Vasopressin V2 receptor","protein":"Vasopressin V2 receptor"}],"modality":"Peptide","drugClass":"carbetocin","explanation":"","oneSentence":"","technicalDetail":"Pabal (carbetocin) is a selective oxytocin receptor agonist, which means it binds to the oxytocin receptor with high affinity and specificity, triggering a cascade of intracellular signaling events that ultimately lead to the contraction of uterine smooth muscle."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/495","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CARBETOCIN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CARBETOCIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:14:21.798179","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:01.579412+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"oxytocin","drugSlug":"oxytocin","fdaApproval":"1980-04-17","genericCount":3,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"carbetocin","indications":{"approved":[{"name":"Atony of uterus","source":"DrugCentral","snomedId":9293002,"regulator":"FDA"},{"name":"Prader-Willi syndrome","source":"DrugCentral","snomedId":89392001,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"oxytocin","brandName":"oxytocin","genericName":"oxytocin","approvalYear":"1980","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07380529","phase":"NA","title":"Comparison of the Effect of Carbetocin Versus Oxytocin in the Prevention of Postpartum Hemorrhage After Emergency Caesarean Section in Antenatal Low-risk Patients","status":"COMPLETED","sponsor":"Ankara Etlik City Hospital","startDate":"2024-10-01","conditions":["Postpartum Hemorrhage \\(PPH\\)"],"enrollment":300,"completionDate":"2025-08-04"},{"nctId":"NCT03899961","phase":"PHASE4","title":"Carbetocin Myocardium Trial 2014 Part 2","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2019-04-02","conditions":["Pregnancy Complications"],"enrollment":240,"completionDate":"2022-04-15"},{"nctId":"NCT07401524","phase":"PHASE4","title":"Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Sheba Medical Center","startDate":"2026-03-01","conditions":["Postpartum Hemorrhage","Twin Pregnancy"],"enrollment":120,"completionDate":"2028-12-01"},{"nctId":"NCT07390864","phase":"NA","title":"Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-01-18","conditions":["Myoma;Uterus"],"enrollment":40,"completionDate":"2026-08-30"},{"nctId":"NCT07353281","phase":"NA","title":"Carbetocin vs Misoprostol for Postpartum Hemorrhage Prevention","status":"NOT_YET_RECRUITING","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2026-01-31","conditions":["Postpartum Complication","Postpartum Hemorrhage"],"enrollment":146,"completionDate":"2028-01-01"},{"nctId":"NCT07318467","phase":"NA","title":"Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-01-01","conditions":["Post Partum Hemorrhage"],"enrollment":80,"completionDate":"2026-06-30"},{"nctId":"NCT06420297","phase":"PHASE3","title":"OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"ACADIA Pharmaceuticals Inc.","startDate":"2024-03-11","conditions":["Hyperphagia in Prader-Willi Syndrome"],"enrollment":160,"completionDate":"2029-06"},{"nctId":"NCT06930391","phase":"NA","title":"Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2025-09-15","conditions":["Postpartum Hemorrhage (Primary)"],"enrollment":40,"completionDate":"2026-06"},{"nctId":"NCT07187544","phase":"NA","title":"Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2025-09","conditions":["Postpartum Hemorrhage (Primary)"],"enrollment":120,"completionDate":"2026-09"},{"nctId":"NCT06776926","phase":"NA","title":"Timing of Carbetocin Administration in Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Mehmet Mete Kırlangıç","startDate":"2025-01-10","conditions":["Postpartum Hemorrhage","Carbetocin"],"enrollment":200,"completionDate":"2025-02-28"},{"nctId":"NCT06173531","phase":"PHASE3","title":"Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"ACADIA Pharmaceuticals Inc.","startDate":"2023-11-27","conditions":["Hyperphagia in Prader-Willi Syndrome"],"enrollment":170,"completionDate":"2025-11"},{"nctId":"NCT06956365","phase":"NA","title":"To Compare the Effects of Oxytocin and Carbetocin on Intraoperative Hemodynamic Changes in Cesarean Section Surgeries.","status":"RECRUITING","sponsor":"Yuzuncu Yil University","startDate":"2024-05-14","conditions":["Cesarean Section"],"enrollment":80,"completionDate":"2025-07-30"},{"nctId":"NCT06946589","phase":"PHASE4","title":"Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section","status":"NOT_YET_RECRUITING","sponsor":"Jordan Leitch","startDate":"2025-08-01","conditions":["Cardiac Ischemia","Cesarian Section"],"enrollment":200,"completionDate":"2027-09-01"},{"nctId":"NCT01262742","phase":"NA","title":"Carbetocin at Elective Cesarean Delivery","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2010-11","conditions":["Postpartum Hemorrhage"],"enrollment":80,"completionDate":"2011-03"},{"nctId":"NCT01968187","phase":"PHASE2","title":"Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2014-01-20","conditions":["Hyperphagia in Prader-Willi Syndrome"],"enrollment":38,"completionDate":"2014-07-16"},{"nctId":"NCT06692621","phase":"","title":"Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-10-04","conditions":["PREG1"],"enrollment":120,"completionDate":"2025-01-10"},{"nctId":"NCT06285409","phase":"NA","title":"Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2024-04-04","conditions":["Postpartum Hemorrhage"],"enrollment":32,"completionDate":"2025-12"},{"nctId":"NCT04866888","phase":"NA","title":"Placenta Accreta Spectrum Outcome After Uterine Conservation","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2021-04-28","conditions":["Placenta Accreta Spectrum"],"enrollment":120,"completionDate":"2026-03-15"},{"nctId":"NCT04304625","phase":"PHASE3","title":"TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2020-08-07","conditions":["Postpartum Hemorrhage"],"enrollment":1380,"completionDate":"2027-09"},{"nctId":"NCT06333340","phase":"NA","title":"Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2025-01-14","conditions":["Post Partum Hemorrhage"],"enrollment":160,"completionDate":"2025-12"},{"nctId":"NCT05924321","phase":"PHASE1","title":"A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2023-05-25","conditions":["Postpartum Hemorrhage"],"enrollment":40,"completionDate":"2023-09-21"},{"nctId":"NCT06060327","phase":"NA","title":"Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-10-15","conditions":["Postpartum Hemorrhage","Blood Loss, Postoperative","Cesarean Section Complications"],"enrollment":440,"completionDate":"2024-06-15"},{"nctId":"NCT05154279","phase":"NA","title":"The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations","status":"RECRUITING","sponsor":"Wael Elbanna Clinic","startDate":"2022-02-27","conditions":["Laparoscopic Myomectomy"],"enrollment":99,"completionDate":"2026-03-30"},{"nctId":"NCT05242783","phase":"NA","title":"The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:","status":"COMPLETED","sponsor":"Wael Elbanna Clinic","startDate":"2022-02-01","conditions":["Myoma"],"enrollment":99,"completionDate":"2024-06-20"},{"nctId":"NCT05170230","phase":"NA","title":"The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations","status":"RECRUITING","sponsor":"Wael Elbanna Clinic","startDate":"2022-02-27","conditions":["Myoma"],"enrollment":99,"completionDate":"2026-06-30"},{"nctId":"NCT06217354","phase":"PHASE1,PHASE2","title":"Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-07-06","conditions":["Obesity, Maternal","Post Partum Hemorrhage"],"enrollment":150,"completionDate":"2023-11-25"},{"nctId":"NCT06159959","phase":"","title":"Carbetocin in the Prevention of Primary Postpartum Haemorrhage","status":"COMPLETED","sponsor":"Ministry of Health and Population, Egypt","startDate":"2023-01-01","conditions":["Post Partum Hemorrhage"],"enrollment":244,"completionDate":"2023-10-30"},{"nctId":"NCT05986266","phase":"PHASE1","title":"Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss","status":"COMPLETED","sponsor":"Egymedicalpedia","startDate":"2023-02-01","conditions":["Uterine Fibroid"],"enrollment":62,"completionDate":"2023-09-15"},{"nctId":"NCT05664659","phase":"PHASE4","title":"Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section","status":"COMPLETED","sponsor":"Ain Shams Maternity Hospital","startDate":"2022-12-20","conditions":["Blood Loss, Surgical","Intrapartum Hemorrhage"],"enrollment":90,"completionDate":"2023-05-20"},{"nctId":"NCT04182360","phase":"NA","title":"Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy.","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2021-10-14","conditions":["Postpartum Hemorrhage","Twin"],"enrollment":30,"completionDate":"2023-04-28"},{"nctId":"NCT05110482","phase":"PHASE4","title":"Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2021-11-30","conditions":["Adverse Effect of Oxytocic Drugs"],"enrollment":38,"completionDate":"2023-06-30"},{"nctId":"NCT03651882","phase":"PHASE4","title":"Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2018-08-07","conditions":["Postpartum Hemorrhage"],"enrollment":550,"completionDate":"2022-01-10"},{"nctId":"NCT05806307","phase":"PHASE4","title":"Methods Decreasing Bleeding in Open Myomectomy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2023-03-15","conditions":["Misoprostol Allergy","Oxytocin Allergy","Tranexamic Acid Allergy","Ethamsylate Allergy","Myoma","Blood Loss, Surgical"],"enrollment":105,"completionDate":"2023-11-30"},{"nctId":"NCT05742854","phase":"PHASE4","title":"Comparison Of The Effects Of Carbetocin And Oxytocin In C-Sectıon","status":"UNKNOWN","sponsor":"Ege University","startDate":"2023-03-09","conditions":["Carbetocin","Oxytocic Drugs Causing Adverse Effects in Therapeutic Use"],"enrollment":200,"completionDate":"2023-06-21"},{"nctId":"NCT05758012","phase":"","title":"Carbetocin Compared To Oxytocin During Cesarean Delivery","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-05-01","conditions":["Cesarean Delivery"],"enrollment":260,"completionDate":"2024-12-01"},{"nctId":"NCT04902729","phase":"NA","title":"Oxytocin vs Carbetocin at Cesarean Delivery in Women With Morbid Obesity","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2021-07-20","conditions":["Post Partum Hemorrhage"],"enrollment":48,"completionDate":"2022-12-09"},{"nctId":"NCT05467462","phase":"NA","title":"Efficacy of Four Different Treatment Regimes on Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2022-08-01","conditions":["Postpartum Hemorrhage"],"enrollment":300,"completionDate":"2023-01-25"},{"nctId":"NCT05670886","phase":"NA","title":"Routine Bilateral Uterine Artery Ligation During the Cesarean Delivery of Multiple Gestation","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-06-01","conditions":["Postpartum Hemorrhage"],"enrollment":110,"completionDate":"2023-01-30"},{"nctId":"NCT05479357","phase":"NA","title":"Carbetocin Versus Oxytocin for Prophylaxis Against Atonic Primary Post-partum Hemorrhage","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2022-07-28","conditions":["Atonic Postpartum Hemorrhage","High Risk Pregnancy"],"enrollment":80,"completionDate":"2022-12-30"},{"nctId":"NCT03649477","phase":"PHASE3","title":"Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome","status":"COMPLETED","sponsor":"Levo Therapeutics, Inc.","startDate":"2018-11-20","conditions":["Prader-Willi Syndrome"],"enrollment":130,"completionDate":"2022-07-09"},{"nctId":"NCT04201665","phase":"NA","title":"EMG for Uterotonic Efficiency Estimation","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2020-09-13","conditions":["Postpartum Hemorrhage"],"enrollment":60,"completionDate":"2022-01-31"},{"nctId":"NCT04482959","phase":"PHASE4","title":"Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy","status":"COMPLETED","sponsor":"Mansoura University Hospital","startDate":"2020-07-15","conditions":["Myoma;Uterus"],"enrollment":40,"completionDate":"2022-02-01"},{"nctId":"NCT05266534","phase":"NA","title":"The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets","status":"RECRUITING","sponsor":"Wael Elbanna Clinic","startDate":"2021-12-30","conditions":["Myoma"],"enrollment":162,"completionDate":"2026-12-30"},{"nctId":"NCT05083910","phase":"NA","title":"Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-section","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2021-07-01","conditions":["Postpartum Hemorrhage"],"enrollment":156,"completionDate":"2022-01-22"},{"nctId":"NCT05099575","phase":"","title":"Protocols for Prevention of PPH During CS in High Risk Group","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2021-10-30","conditions":["Atonic PPH"],"enrollment":448,"completionDate":"2022-10-30"},{"nctId":"NCT03404544","phase":"PHASE4","title":"Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus.","status":"COMPLETED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2018-06-11","conditions":["Cesarean Section Complications","Hemodynamic Instability"],"enrollment":70,"completionDate":"2021-01-15"},{"nctId":"NCT03870503","phase":"NA","title":"Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2019-04-01","conditions":["Postpartum Hemorrhage"],"enrollment":135,"completionDate":"2021-08-01"},{"nctId":"NCT03870256","phase":"NA","title":"Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2019-04-01","conditions":["Post Partum Hemorrhage"],"enrollment":135,"completionDate":"2021-09-01"},{"nctId":"NCT02044549","phase":"PHASE4","title":"Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section","status":"COMPLETED","sponsor":"Cairo University","startDate":"2014-06","conditions":["Postpartum Hemorrhage","Blood Loss"],"enrollment":300,"completionDate":"2015-12"},{"nctId":"NCT02528136","phase":"PHASE4","title":"The Clinical Carbetocin Myocardium Trial","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2015-09","conditions":["Pregnancy"],"enrollment":40,"completionDate":"2019-01-28"},{"nctId":"NCT03716076","phase":"PHASE4","title":"Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2018-11-01","conditions":["Cardiac Arrythmias"],"enrollment":50,"completionDate":"2020-04-24"},{"nctId":"NCT03168698","phase":"NA","title":"Carbetocin vs. Oxytocin at Elective Cesarean Section","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2017-05-25","conditions":["Postpartum Hemorrhage"],"enrollment":278,"completionDate":"2020-12-18"},{"nctId":"NCT04756661","phase":"NA","title":"Uterotonics for Severe Preeclampsia","status":"COMPLETED","sponsor":"Assiut University","startDate":"2020-01-01","conditions":["Preeclampsia Severe"],"enrollment":124,"completionDate":"2021-02-10"},{"nctId":"NCT02277041","phase":"PHASE4","title":"Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S.","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2014-10","conditions":["Postpartum Hemorrhage"],"enrollment":200,"completionDate":"2021-04"},{"nctId":"NCT02277067","phase":"PHASE4","title":"Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2014-10","conditions":["Postpartum Hemorrhage"],"enrollment":200,"completionDate":"2021-08"},{"nctId":"NCT04595812","phase":"PHASE4","title":"Methods to Reduce Blood Loss in Abdominal Myomectomy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-11-01","conditions":["Abdominal Myomectomy","Blood Loss"],"enrollment":120,"completionDate":"2022-09-15"},{"nctId":"NCT03578263","phase":"NA","title":"Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2018-04-01","conditions":["Cesarean Section Complications"],"enrollment":220,"completionDate":"2020-08-01"},{"nctId":"NCT03708497","phase":"NA","title":"Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2018-12-01","conditions":["Postpartum Hemorrhage"],"enrollment":360,"completionDate":"2020-07-01"},{"nctId":"NCT03710317","phase":"NA","title":"Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean Section","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2018-12-01","conditions":["Cesarean Section Complications"],"enrollment":400,"completionDate":"2020-08-01"},{"nctId":"NCT02786992","phase":"PHASE2,PHASE3","title":"Misoprostol+Oxytocin vs. Carbetocin in CS","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2016-05","conditions":["Cesarean Section"],"enrollment":600,"completionDate":"2020-01"},{"nctId":"NCT04357015","phase":"PHASE4","title":"Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-05-01","conditions":["Myomectomy"],"enrollment":153,"completionDate":"2020-10-20"},{"nctId":"NCT04083625","phase":"PHASE4","title":"the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-09-10","conditions":["Abdominal Myomectomy"],"enrollment":138,"completionDate":"2020-02-20"},{"nctId":"NCT04313218","phase":"","title":"Carbetocin Versus Misoprostol. A Retrospective Comparative Study","status":"COMPLETED","sponsor":"Port Said University hospital","startDate":"2018-01-01","conditions":["Cesarean Section Complications"],"enrollment":300,"completionDate":"2020-02-28"},{"nctId":"NCT04300452","phase":"PHASE4","title":"Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage","status":"UNKNOWN","sponsor":"National and Kapodistrian University of Athens","startDate":"2018-04-05","conditions":["Postpartum Hemorrhage"],"enrollment":100,"completionDate":"2020-09-30"},{"nctId":"NCT03693599","phase":"PHASE4","title":"Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-10-01","conditions":["Post Partum Hemorrhage"],"enrollment":1200,"completionDate":"2019-09-30"},{"nctId":"NCT03556852","phase":"PHASE4","title":"CARBETOCIN VERSUS RECTAL MISOPROSTOL FOR MANAGEMENT OF THIRD STAGE OF LABOR IN WOMEN AT LOW RISK OF POSTPARTUM HEMORRHAGE","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-07-02","conditions":["Postpartum Hemorrhage"],"enrollment":150,"completionDate":"2019-05-30"},{"nctId":"NCT04089176","phase":"EARLY_PHASE1","title":"Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH","status":"COMPLETED","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2019-02-01","conditions":["Postpartum Hemorrhage","Cesarean Section","High Risk Pregnancy"],"enrollment":120,"completionDate":"2019-05-31"},{"nctId":"NCT03672045","phase":"NA","title":"Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2018-11-19","conditions":["Postpartum Hemorrhage"],"enrollment":30,"completionDate":"2019-05-17"},{"nctId":"NCT03959436","phase":"","title":"Database Evaluating Outcomes of Using Carbetocin as the Primary Uterotonic Following Cesarean Delivery","status":"COMPLETED","sponsor":"Maisonneuve-Rosemont Hospital","startDate":"2017-03-29","conditions":["Carbetocin","Cesarean Section Complications","Uterotonics","Uterine Atony With Hemorrhage"],"enrollment":612,"completionDate":"2018-03-16"},{"nctId":"NCT03939806","phase":"","title":"Effects of Oxytocin and Carbetocin on Renal System in Cesarean Sections","status":"UNKNOWN","sponsor":"Ufuk University","startDate":"2019-05","conditions":["Postpartum Hemorrhage"],"enrollment":100,"completionDate":"2019-06"},{"nctId":"NCT03777878","phase":"NA","title":"Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2019-01-01","conditions":["Cesarean Section Complications"],"enrollment":400,"completionDate":"2021-05-01"},{"nctId":"NCT03755531","phase":"PHASE4","title":"Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery","status":"COMPLETED","sponsor":"Al-Kindy College of Medicine","startDate":"2018-01-04","conditions":["Postpartum Hemorrhage (Primary)"],"enrollment":300,"completionDate":"2018-08-01"},{"nctId":"NCT02216383","phase":"PHASE3","title":"Intramuscular Oxytocics: A Randomised Control Trial","status":"COMPLETED","sponsor":"North Bristol NHS Trust","startDate":"2015-02","conditions":["Post Partum Haemorrhage"],"enrollment":5798,"completionDate":"2018-10-30"},{"nctId":"NCT02642263","phase":"PHASE4","title":"Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section Pain","status":"UNKNOWN","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2019-02-01","conditions":["Cesarean Delivery"],"enrollment":78,"completionDate":"2022-01"},{"nctId":"NCT02221531","phase":"PHASE4","title":"Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2014-08","conditions":["Complications; Cesarean Section","Anesthesia; Reaction"],"enrollment":140,"completionDate":"2015-11"},{"nctId":"NCT02086994","phase":"PHASE3","title":"Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus Misoprostol","status":"COMPLETED","sponsor":"khalid abd aziz mohamed","startDate":"2013-03","conditions":["Severe Pre-eclampsia, Postpartum Condition or Complication"],"enrollment":60,"completionDate":"2015-08"},{"nctId":"NCT02391636","phase":"PHASE4","title":"Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage","status":"COMPLETED","sponsor":"Ghamra Military Hospital","startDate":"2015-02","conditions":["Postpartum Hemorrhage"],"enrollment":264,"completionDate":"2016-12"},{"nctId":"NCT02303418","phase":"PHASE3","title":"Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2014-11","conditions":["Post Partum Haemorrhage"],"enrollment":500,"completionDate":""},{"nctId":"NCT02636816","phase":"PHASE4","title":"Cardiovascular Effects of Carbetocin Given During Elective Cesarean","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2016-03","conditions":["Effect of Carbetocin on Cardiovascular System","Pregnancy"],"enrollment":57,"completionDate":"2016-06"},{"nctId":"NCT02410759","phase":"PHASE3","title":"Carbetocin Versus Ergometrine in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-04","conditions":["Post Partum Hemorrhage"],"enrollment":200,"completionDate":""},{"nctId":"NCT02304055","phase":"PHASE3","title":"Carbetocin Versus Oxytocin in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally: A Randomised Controlled Trial","status":"COMPLETED","sponsor":"Cairo University","startDate":"2013-05","conditions":["Obstetrics"],"enrollment":100,"completionDate":""},{"nctId":"NCT02304042","phase":"PHASE3","title":"Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Delivered Vaginally With at Least 2 Risk Factors for Atonic PPH: A Randomised Controlled Trial","status":"COMPLETED","sponsor":"Cairo University","startDate":"2014-11","conditions":["Delivery"],"enrollment":200,"completionDate":"2015-07"},{"nctId":"NCT02264769","phase":"NA","title":"Carbetocin at Elective Cesarean Delivery Part 4","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2014-10","conditions":["Postpartum Hemorrhage"],"enrollment":110,"completionDate":"2015-05"},{"nctId":"NCT02101567","phase":"PHASE4","title":"Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2014-05","conditions":["Bleeding","Anemia"],"enrollment":200,"completionDate":"2015-04"},{"nctId":"NCT02396303","phase":"EARLY_PHASE1","title":"Carbetocin Versus Oxytocin in Caesarean Section for the Control of Postpartum Haemorrhage","status":"UNKNOWN","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2015-06","conditions":["Postpartum Haemorrhage"],"enrollment":100,"completionDate":"2015-11"},{"nctId":"NCT01719952","phase":"NA","title":"Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin","status":"COMPLETED","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2012-01","conditions":["Pregnancy Related","Anaesthesia"],"enrollment":50,"completionDate":"2014-01"},{"nctId":"NCT01918475","phase":"NA","title":"Analgesic Effect of Oxytocin Receptor Modulation","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2013-07","conditions":["Pain","Hyperalgesia","Central Sensitization"],"enrollment":25,"completionDate":"2014-12"},{"nctId":"NCT01382732","phase":"PHASE3","title":"Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia","status":"UNKNOWN","sponsor":"Saint Thomas Hospital, Panama","startDate":"2012-01","conditions":["Severe Preeclampsia","Postpartum Hemorrhage"],"enrollment":636,"completionDate":"2016-01"},{"nctId":"NCT00977769","phase":"PHASE4","title":"Carbetocin Versus Oxytocin and Hemodynamic Effects","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2009-11","conditions":["Effects of; Anesthesia, in Pregnancy"],"enrollment":76,"completionDate":"2011-10"},{"nctId":"NCT02079558","phase":"PHASE2","title":"Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section","status":"COMPLETED","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2012-09","conditions":["Postpartum Hemorrhage"],"enrollment":220,"completionDate":"2013-09"},{"nctId":"NCT02053922","phase":"PHASE3","title":"The Use of Oxytocin, Carbetocin and Buccal Misoprostol in Patients Undergoing Elective Cesarean Section (CS)","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2012-12","conditions":["Postpartum Hemorrhage"],"enrollment":270,"completionDate":"2013-08"},{"nctId":"NCT01827124","phase":"PHASE4","title":"Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption","status":"UNKNOWN","sponsor":"Wafaa Uthman Ahmed","startDate":"2013-04","conditions":["CARBETOCIN FOR PREVENTION OF PLACENTAL RETAINED"],"enrollment":140,"completionDate":"2013-12"},{"nctId":"NCT01600612","phase":"NA","title":"Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2012-09","conditions":["Postpartum Hemorrhage"],"enrollment":300,"completionDate":"2013-07"},{"nctId":"NCT01651130","phase":"NA","title":"Carbetocin at Elective Cesarean Delivery Part 3","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2012-06","conditions":["Postpartum Hemorrhage"],"enrollment":40,"completionDate":"2012-08"},{"nctId":"NCT01725243","phase":"NA","title":"Carbetocin at Cesarean Delivery for Labor Arrest","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2012-11","conditions":["Postpartum Hemorrhage"],"enrollment":40,"completionDate":"2013-04"},{"nctId":"NCT01630187","phase":"PHASE4","title":"Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section","status":"COMPLETED","sponsor":"Laval University","startDate":"2012-04","conditions":["Uterine Atony","Post-partum Hemorrhage"],"enrollment":72,"completionDate":"2012-07"},{"nctId":"NCT01579201","phase":"PHASE4","title":"ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery","status":"UNKNOWN","sponsor":"Maisonneuve-Rosemont Hospital","startDate":"2012-03","conditions":["Postpartum Hemorrhage","Uterine Atony"],"enrollment":40,"completionDate":"2013-03"},{"nctId":"NCT01689298","phase":"NA","title":"Carbetocin vs. Oxytocin: In-vitro Myometrial Contractions With and Without Oxytocin Pre-treatment","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2010-01","conditions":["Postpartum Hemorrhage"],"enrollment":20,"completionDate":"2012-08"},{"nctId":"NCT01428817","phase":"NA","title":"Carbetocin at Elective Cesarean Delivery Part 2","status":"COMPLETED","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2011-06","conditions":["Postpartum Hemorrhage"],"enrollment":120,"completionDate":"2011-12"},{"nctId":"NCT01277978","phase":"","title":"Haemodynamic Effects of Oxytocin and Carbetocin","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2008-01","conditions":["Pregnancy Related","Cesarean Section; Complications","Adverse Reaction to Oxytocic Agents"],"enrollment":84,"completionDate":"2008-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"006738","UNII":"88TWF8015Y","CHEBI":"CHEBI:59204","INN_ID":"5014","UMLSCUI":"C0054670","chemblId":"CHEMBL3301668","ChEMBL_ID":"CHEMBL3301668","KEGG_DRUG":"D07229","DRUGBANK_ID":"DB01282","PUBCHEM_CID":"16681432","SNOMEDCT_US":"423594000","IUPHAR_LIGAND_ID":"11169","MESH_SUPPLEMENTAL_RECORD_UI":"C020731"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Ferring Pharmaceuticals Ltd","relationship":"Current Owner"}],"publicationCount":403,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"H01BB03","allCodes":["H01BB03"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 23","pmid":"41866582","title":"Telemedical management of severe postpartum hemorrhagic vaginal discharge in a sow - a case report.","journal":"Porcine health management"},{"date":"2026 Mar 6","pmid":"41844474","title":"Uterotonics in pregnant patients with cardiac disease: a focused review.","journal":"International journal of obstetric anesthesia"},{"date":"2026 Feb 24","pmid":"41736500","title":"Prophylactic carbetocin versus oxytocin following vaginal delivery among women with high risk for postpartum hemorrhage: A before-and-after study.","journal":"Acta obstetricia et gynecologica Scandinavica"},{"date":"2026 Apr","pmid":"41730820","title":"Carbetocin - a long-acting oxytocin analogue - increases the blood supply to the reproductive tract of rams.","journal":"Domestic animal endocrinology"},{"date":"2026 Jun","pmid":"41722142","title":"Effect of dimethyl sulfoxide (DMSO) associated with oxytocin (carbetocin) on collagenase activity (in vitro) and cervical penetrability (in vivo) in sheep.","journal":"Theriogenology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Ferring Pharmaceuticals Ltd","companyId":"ferring-pharmaceuticals-ltd","modality":"Recombinant protein","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":6,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:01.579412+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}